FDA NDC Directory · JSON-LD · Markdown

Rizatriptan Benzoate

NDC 57237-086 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerRising Pharma Holdings, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203062
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsRIZATRIPTAN BENZOATE (10 mg/1)
Marketing started20130701
Package count1

External sources

Source: openFDA. Public-domain (CC0).